Search results for "osteoarthriti"

showing 10 items of 346 documents

Management of chronic knee osteoarthritis pain: Where are we going?

2016

03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industryPhysical therapyMedicinePhysical Therapy Sports Therapy and Rehabilitation030212 general & internal medicineGeneral MedicineOsteoarthritisbusinessmedicine.disease030217 neurology & neurosurgeryManual Therapy
researchProduct

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoart…

2019

Berenbaum, Francis/0000-0001-8252-7815; Dennison, Elaine/0000-0002-3048-4961; Bindels, Laure B./0000-0003-3747-3234; Cooper, Cyrus/0000-0003-3510-0709 WOS:000491638300002 PubMed ID: 31437484 The prevalence of osteoarthritis (OA) increases not only because of longer life expectancy but also because of the modern lifestyle, in particular physical inactivity and diets low in fiber and rich in sugar and saturated fats, which promote chronic low-grade inflammation and obesity. Adverse alterations of the gut microbiota (GMB) composition, called microbial dysbiosis, may favor metabolic syndrome and inflammaging, two important components of OA onset and evolution. Considering the burden of OA and t…

0301 basic medicineAgingmedicine.medical_specialtyOsteoporosisPsychological interventionOsteoarthritisGut microbiotaGut floraDysbiosis; Gut microbiota; Inflammaging; Modern diet; Obesity; OsteoarthritisBiochemistry03 medical and health sciences0302 clinical medicineOsteoarthritismedicineAnimalsHumansMusculoskeletal DiseasesObesityModern dietIntensive care medicineMolecular BiologySocieties MedicalInflammationbiologybusiness.industrymedicine.diseasebiology.organism_classificationObesityInflammagingDysbiosiInflammaging ObesityGastrointestinal MicrobiomeEurope030104 developmental biologyNeurologyOsteoporosisDysbiosisObservational studyOsteoarthritiMetabolic syndromebusinessDysbiosis030217 neurology & neurosurgeryBiotechnology
researchProduct

Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.

2017

Natural products or nutraceuticals promote anti-aging, anti-cancer and other health-enhancing effects. A key target of the effects of natural products may be the regulation of the PI3K/PTEN/Akt/mTORC1/GSK-3 pathway. This review will focus on the effects of curcumin (CUR), berberine (BBR) and resveratrol (RES), on the PI3K/PTEN/Akt/mTORC1/GSK-3 pathway, with a special focus on GSK-3. These natural products may regulate the pathway by multiple mechanisms including: reactive oxygen species (ROS), cytokine receptors, mirco-RNAs (miRs) and many others. CUR is present the root of turmeric (Curcuma longa). CUR is used in the treatment of many disorders, especially in those involving inflammatory p…

0301 basic medicineCancer ResearchCurcuminBerberinemTORC1PharmacologyResveratrolMechanistic Target of Rapamycin Complex 1Protective AgentsNatural product03 medical and health scienceschemistry.chemical_compoundGlycogen Synthase Kinase 3Phosphatidylinositol 3-KinasesBerberineGeneticNeoplasmsOsteoarthritisStilbenesGeneticsPTENHumansCurcumaMolecular BiologyProtein kinase BPI3K/AKT/mTOR pathwayInflammationNatural productsbiologyBerberine; Curcumin; Natural products; ResveratrolPTEN PhosphohydrolaseNeurodegenerative Diseasesbiology.organism_classification030104 developmental biologyBiochemistrychemistryGene Expression RegulationCardiovascular DiseasesResveratrolbiology.proteinCurcuminMolecular MedicineProto-Oncogene Proteins c-aktSignal Transduction
researchProduct

Gene therapy for chondral and osteochondral regeneration: is the future now?

2017

Gene therapy might represent a promising strategy for chondral and osteochondral defects repair by balancing the management of temporary joint mechanical incompetence with altered metabolic and inflammatory homeostasis. This review analysed preclinical and clinical studies on gene therapy for the repair of articular cartilage defects performed over the last 10 years, focussing on expression vectors (non-viral and viral), type of genes delivered and gene therapy procedures (direct or indirect). Plasmids (non-viral expression vectors) and adenovirus (viral vectors) were the most employed vectors in preclinical studies. Genes delivered encoded mainly for growth factors, followed by transcripti…

0301 basic medicineCartilage ArticularExpression vectorPathologymedicine.medical_specialtyCell signalingCartilage repair; Expression vectors; Gene therapy procedures; Osteoarthritis; Regenerative medicine; Molecular Medicine; Molecular Biology; Pharmacology; Cellular and Molecular Neuroscience; Cell BiologyBone RegenerationInflammatory arthritisGenetic enhancementGene therapy procedureOsteoarthritisViral vector03 medical and health sciencesCellular and Molecular NeuroscienceCartilage repairChondrocytesInterferonSettore BIO/13 - Biologia ApplicataOsteoarthritismedicineAnimalsHumansRegenerationMolecular BiologyPharmacologyExpression vectorbusiness.industryRegeneration (biology)Cell BiologyGenetic Therapymedicine.disease030104 developmental biologyRegenerative medicineCancer researchMolecular MedicineOsteoarthritibusinessmedicine.drugCellular and molecular life sciences : CMLS
researchProduct

Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament trans…

2016

[EN] Context: The efficacy of the combination chondroitin sulfate-glucosamine (CS-GlcN) in the treatment of knee osteoarthritis (OA) has been suggested in recent clinical studies. In vitro reports have also suggested anti-inflammatory and anti-resorptive effects of this combination. Objective: The aim of this study was to characterize the effects of CS-GlcN on joint degradation in vivo including the assessment of inflammation and bone metabolism in a model of OA. Materials and methods: We have used the OA model induced by anterior cruciate ligament transection (ACLT) in ovariectomised rats. CS-GlcN was administered daily (oral gavage) from week 0 until week 12 after ovariectomy at the dose …

0301 basic medicineCartilage Articularmedicine.medical_specialtyAnterior cruciate ligamentOvariectomyType II collagenOsteoarthritisProtective AgentsBone and BonesBone remodeling03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOsteoprotegerinGlucosamineInternal medicineOsteoarthritisMedicineAnimalsChondroitin sulfateAnterior cruciate ligament transectionAnterior Cruciate LigamentRats Wistar030203 arthritis & rheumatologyPharmacologyGlucosaminebusiness.industryCartilageAnterior Cruciate Ligament InjuriesChondroitin SulfatesGeneral MedicineX-Ray MicrotomographyOsteoarthritis Kneemedicine.diseaseChondroitin sulfate-glucosamine Ovariectomised ratscarbohydrates (lipids)Disease Models Animal030104 developmental biologymedicine.anatomical_structureEndocrinologychemistryDrug Therapy CombinationFemaleJointsInflammation MediatorsbusinessBiomarkersModel
researchProduct

Evaluation of Long-Time Decoction-Detoxicated Hei-Shun-Pian (Processed Aconitum carmichaeli Debeaux Lateral Root With Peel) for Its Acute Toxicity an…

2020

Background As a degenerative joint disease with severe cartilage destruction and pain, osteoarthritis (OA) has no satisfactory therapy to date. In traditional Chinese medicine (TCM), Aconitum carmichaeli Debeaux derived Hei-shun-pian (Hsp) has been developed for joint pain treatment. However, it causes adverse events in OA patients. Long-time decoction has been traditionally applied to reduce the aconite toxicity of Hsp and other aconite herbs, but its detoxifying effect is uncertain. Methods Hsp was extracted with dilute decoction times (30, 60, and 120 min) and evaluated by toxicological, chemical, pharmacological assays. Acute toxicity assay and chemical analysis were employed to determi…

0301 basic medicineChondrocyte hypertrophyDecoctionOsteoarthritisPharmacology03 medical and health scienceschemistry.chemical_compoundtraditional Chinese medicine0302 clinical medicineTherapeutic indexAconitum carmichaeliMedicineAconitinePharmacology (medical)Viability assayOriginal ResearchPharmacologybusiness.industrylcsh:RM1-950monosodium iodoacetateanalgesiapain behaviourmedicine.diseaseAcute toxicityosteoarthritis030104 developmental biologylcsh:Therapeutics. Pharmacologychemistry030220 oncology & carcinogenesisToxicitybusinessFrontiers in Pharmacology
researchProduct

Multidimensional frailty increases cardiovascular risk in older people: An 8-year longitudinal cohort study in the Osteoarthritis Initiative.

2021

Background:\ud \ud Cardiovascular diseases (CVDs) are the most important cause of mortality and an important cause of disability. Frailty seems to be associated with higher cardiovascular risk, but limited research has been done using a multidimensional approach to frailty. Thus, the present study aimed to investigate whether the multidimensional prognostic index (MPI), based on comprehensive geriatric assessment (CGA), is associated with CVD risk in the Osteoarthritis Initiative (OAI) study.\ud \ud Methods:\ud \ud Community-dwellers affected by knee OA or at high risk for this condition were followed for 8 years. A standardized CGA including information on functional, nutritional, mood, co…

0301 basic medicineGerontologyAgingOsteoarthritisComprehensive geriatric assessmentLogistic regressionBiochemistryCohort Studies03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeRisk FactorsMultidimensional prognostic indexOsteoarthritisGeneticsRisk of mortalityMedicineHumansLongitudinal StudiesLongitudinal cohortMolecular BiologyGeriatric AssessmentAgedFrailtybusiness.industryConfoundingCell BiologyCardiovascular diseaseCardiovascular riskmedicine.diseasePrognosis030104 developmental biologyMoodOsteoarthritis InitiativeCardiovascular DiseasesHeart Disease Risk FactorsQuality of LifeFemalebusinessOlder people030217 neurology & neurosurgeryExperimental gerontology
researchProduct

Dietary Magnesium and Incident Frailty in Older People at Risk for Knee Osteoarthritis: An Eight-Year Longitudinal Study.

2017

Inadequate magnesium (Mg) intake is associated with lower physical performance, but the relationship with frailty in older people is unclear. Therefore, we aimed to investigate whether higher dietary Mg intake is associated with a lower risk of frailty in a large cohort of North American individuals. Details regarding Mg intake were recorded through a food-frequency questionnaire (FFQ) and categorized as greater than/equal to Recommended Dietary Allowance (RDA) vs. lower. Frailty was defined using the Study of Osteoporotic Fractures index. Multivariable Cox’s regression analyses, calculating hazard ratios (HRs) with 95% confidence intervals (CIs), were undertaken by sex. In total, 4421 in…

0301 basic medicineMaleLongitudinal studymedicine.medical_specialtySettore MED/09 - Medicina InternaFrail ElderlyOsteoarthritis Initiative; frailty; magnesium; older adultslcsh:TX341-641OsteoarthritisfrailtymagnesiumLower riskRecommended Dietary AllowancesArticle03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumans030212 general & internal medicineLongitudinal StudiesOlder adultolder adultsAgedMagnesium/administration & dosage030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryConfoundingHazard ratioOsteoarthritis Knee/etiologyfrailty; magnesium; older adults; Osteoarthritis InitiativeMiddle AgedOsteoarthritis Kneemedicine.diseaseConfidence intervalDietFrailty; Magnesium; Older adults; Osteoarthritis Initiative; Food Science; Nutrition and DieteticsDietary Reference IntakeOsteoarthritis InitiativePhysical therapyFemaleOlder peoplebusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Adherence to the Mediterranean diet is associated with better quality of life: data from the Osteoarthritis Initiative

2016

BACKGROUND The Mediterranean diet has positively influenced various medical conditions, but only a paucity of studies has considered the relation between the Mediterranean diet and quality of life (QOL) among people living in North America. OBJECTIVE We investigated whether a higher adherence to the Mediterranean diet (aMED) was associated with better QOL and decreased pain, stiffness, disability, and depression in a large cohort of North Americans from the Osteoarthritis Initiative. DESIGN aMED was evaluated through a validated Mediterranean diet score categorized into quintiles. Outcomes of interest were QOL [assessed with the 12-Item Short-Form Health Outcome Survey (SF-12)]; disability,…

0301 basic medicineMaleMultivariate analysisMediterranean dietCross-sectional studyMedicine (miscellaneous)MediterraneanLogistic regressionDiet MediterraneanBody Mass Index0302 clinical medicineMediterranean diet; depression; disability; pain; quality of life osteoarthritis initiativeQuality of lifeSurveys and Questionnaires030212 general & internal medicineNutrition and DieteticsCenter for Epidemiologic Studies Depression ScaleMiddle AgeddepressionFemalemedicine.medical_specialtyWOMACquality of life osteoarthritis initiativePaindepression Mediterranean diet quality of life osteoarthritis initiative pain disability03 medical and health sciencesNutritional Epidemiology and Public HealthMediterranean dietOsteoarthritismedicineHumansAged030109 nutrition & dieteticsbusiness.industryDietMediterranean diet; depression; disability; pain; quality of life osteoarthritis initiative; Aged; Body Mass Index; Cross-Sectional Studies; Energy Intake; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; North America; Osteoarthritis; Pain; Quality of Life; Socioeconomic Factors; Surveys and Questionnaires; Diet Mediterranean; Patient ComplianceCross-Sectional StudiesLogistic ModelsdisabilitySocioeconomic FactorsMultivariate AnalysisNorth AmericaPhysical therapyLinear ModelsQuality of LifePatient CompliancebusinessEnergy IntakeBody mass indexDemography
researchProduct

Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes

2018

[EN] Background/Aims: Chronic inflammation contributes to cartilage degeneration during the progression of osteoarthritis (OA). Adipose tissue-derived mesenchymal stem cells (ADMSC) show great potential to treat inflammatory and degradative processes in OA and have demonstrated paracrine effects in chondrocytes. In the present work, we have isolated and characterized the extracellular vesicles from human AD-MSC to investigate their role in the chondroprotective actions of these cells. Methods: AD-MSC were isolated by collagenase treatment from adipose tissue from healthy individuals subjected to abdominal lipectomy surgery. Microvesicles and exosomes were obtained from conditioned medium by…

0301 basic medicineMalePhysiologyCell SurvivalAdipose tissue-derived mesenchymal stem cellsAdipose tissueInflammationNitric OxideExtracellular vesiclesChondrocytelcsh:PhysiologyDinoprostonelcsh:Biochemistry03 medical and health sciencesChondrocytesOsteoarthritismedicineHumanslcsh:QD415-436Cells CulturedAgedInflammationlcsh:QP1-981ChemistryMesenchymal stem cellMesenchymal Stem CellsMiddle AgedExtracellular vesiclesChondrocyteMicrovesiclesMatrix MetalloproteinasesCell biology030104 developmental biologymedicine.anatomical_structureAdipose TissueCytokinesFemalemedicine.symptom
researchProduct